scispace - formally typeset
L

Leonid Churilov

Researcher at University of Melbourne

Publications -  529
Citations -  17307

Leonid Churilov is an academic researcher from University of Melbourne. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 45, co-authored 467 publications receiving 13155 citations. Previous affiliations of Leonid Churilov include Monash University, Clayton campus & Florey Institute of Neuroscience and Mental Health.

Papers
More filters
Journal ArticleDOI

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

TL;DR: In patients with ischemic stroke with a proximal cerebral arterial occlusion and salvageable tissue on CT perfusion imaging, early thrombectomy with the Solitaire FR stent retriever, as compared with alteplase alone, improved reperfusion, early neurologic recovery, and functional outcome.
Journal ArticleDOI

Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial

TL;DR: The higher dose, very early mobilisation protocol was associated with a reduction in the odds of a favourable outcome at 3 months and should affect clinical practice by refining present guidelines; however, clinical recommendations should be informed by future analyses of dose-response associations.
Journal ArticleDOI

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

TL;DR: Tenecteplase before thrombectomy was associated with a higher incidence of reperfusion and better functional outcome than alteplase among patients with ischemic stroke treated within 4.5 hours after symptom onset.
Journal ArticleDOI

Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data

Bruce C.V. Campbell, +267 more
- 13 Jul 2019 - 
TL;DR: Patients with ischaemic stroke 4·5-9 h from stroke onset or wake-up stroke with salvageable brain tissue who were treated with alteplase achieved better functional outcomes than did patients given placebo, and this increase in the rate of symptomatic intracerebral haemorrhage did not negate the overall net benefit of thrombolysis.